| abstract |
1. The compound of formula I or its pharmaceutically acceptable salts, solvates or prodrugs, where R is aryl, heteroaryl, aralkyl or cycloalkyl, R is aryl, heteroaryl, cycloalkyl or heterocyclyl, m is 0 to 4, R is hydrogen, C-C1-6 alkyl, halogen (CC) alkyl, cyano, nitro, amino, hydroxyl, alkoxy, heteroalkyl, heterocyclyl, hydroxycycloalkyl or —C (═O) —R, where R is hydrogen, C-Calkyl, heteroalkyl, aryl, aralkyl, heteroaryl or heterocyclyl, k is 0 or 1 , B means O, S (O), CH (OR), NR or C (= O), with j being 0, 1 or 2, R is hydrogen or (CC) alkyl, R hydrogen, (C — C) alkyl, —C (═O) —R or —SOR, where R is C-Calkyl, aryl or aralkyl, and R is C-Calkyl. 2. The compound according to claim 1, where k is 0.3. The compound according to claim 2, where R is optionally substituted phenyl. The compound according to claim 3, where R is 2-halogenophenyl or 2,4-dihalogenophenyl. A compound according to claim 3, wherein R1 is optionally substituted phenyl, optionally substituted thienyl, optionally substituted pyridyl, optionally substituted indolyl, optionally substituted benzothienyl or optionally substituted benzofuranyl. The compound according to claim 1, which is characterized by the formula II where A, R, R, m and R have the meanings as defined in clause 1.7. The compound according to claim 6, which is characterized by the formula III where p and q are each independently 0 to 4, R each independently represents a halogen atom, C-C1-6 alkyl, alkoxy, halo (CC) alkyl or cyano, R each independently represents a halogen atom, C-C1-6 , halogen (CC) alkyl, cyano, heteroalkyl, heterocyclyl, hydroxycycloalkyl or —C (= O) —R, wherein R is C-Calkyl, heteroalkyl, aryl, aralkyl, heteroaryl or heterocyclyl, and am and R are as defined in 7.8. The compound according to claim 7, which is characterized |